Skip to main content

2 Result(s)

within Lindsey J. Anstine Remove this filter

and

  1. Article

    Open Access

    KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene

    Triple-negative breast cancer (TNBC) is characterized by high rates of recurrence and poor overall survival. This is due, in part, to a deficiency of targeted therapies, making it essential to identify therape...

    Melyssa S. Roberts, Lindsey J. Anstine, Viviane S. Finke… in Breast Cancer Research (2020)

    Download PDF (1463 KB) View Article

  2. No Access

    Chapter

    Molecular and Cellular Developments in Heart Valve Development and Disease

    The prevalence of heart valve disease is estimated at 2.5% and this number is likely to increase with the steady rise in life expectancy and associated degenerative pathology. Affected individuals suffer signi...

    Lindsey J. Anstine, Anthony S. Baker, Joy Lincoln in Advances in Heart Valve Biomechanics (2018)